Sage Journals: Discover world-class research

Retricted access

Research article

First published 2018-5

Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database

Yomei Matsuoka, Mamoru Narukawa

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2000-10

A Pilot Evaluation of the Anti-Inflammatory Activity of Culcasia scandens,a Traditional Antirheumatic Agent

Charles O. Okoli, Peter A. Akah

Journal of Integrative and Complementary Medicine

Retricted access

Case report

First published 2016-7

Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy

Melissa Laub, Robert Fraser, Jonathan Kurche [...]

Journal of Intensive Care Medicine

Open access

Review article

First published 2023-12

The Methotrexate Story: How did a Cancer Chemotherapeutic Agent Become a Disease-modifying Antirheumatic Drug

Anand N. Malaviya, Astha Sareen

Indian Journal of Rheumatology

Retricted access

Research article

First published 2020-02

Technology-Enabled Outreach to Patients Taking High-Risk Medications Reduces a Quality Gap in Completion of Clinical Laboratory Testing

Marsha A. Raebel, Susan M. Shetterly, Bharati Bhardwaja [...]

Population Health Management

Retricted access

Research article

First published 2005-12

Dose Intensification with Infliximab in Patients with Rheumatoid Arthritis

Ariel Berger, John Edelsberg, Tracy T Li [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2001-02

The Year in Review: Rheumatology

Vitalina Rozenfeld, Larisa Chagan, Evgenia Kleyman

Journal of Pharmacy Practice

Free access

Review article

First published 2016-10

Combination therapy with biologic agents in rheumatic diseases: current and future prospects

Kentaro Inui, Tatsuya Koike

Therapeutic Advances in Musculoskeletal Disease

Free access

Review article

First published 2015-7

Psoriatic arthritis: latest treatments and their place in therapy

Eun Jin Kang, Arthur Kavanaugh

Sage Open Chronic Disease

Open access

Research article

First published 2022

Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective,multicenter real-life study

Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti [...]

Therapeutic Advances in Musculoskeletal Disease

Search results